Stock Events

Stock Events

Search...

Willow Biosciences

0

00

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

-

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

13NovExpected

Q1 2024

Q2 2024

Next

999

333

-333

-999

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow WLLW.CN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

CRISPR Therapeutics

CRISPR Therapeutics is involved in gene editing, a technology that can be seen as complementary or competitive to biosynthesis in developing therapeutic products.

Editas Medicine

Editas Medicine operates in the genome editing field, which competes with biosynthesis for applications in medicine and agriculture.

Intellia Therapeutics

Intellia Therapeutics is another key player in the CRISPR space, potentially competing with Willow in the development of novel therapeutics.

Evogene utilizes computational biology to improve product development in agriculture, which could compete with Willow's biosynthetic approaches in the same sector.

Synlogic operates in synthetic biology, using engineered bacteria for therapeutic purposes, which is a direct competitor to Willow's biosynthesis technologies.

Adaptive Biotechnologies

Adaptive Biotechnologies focuses on the immune-driven discovery and development of therapeutics, potentially competing in the biotech space with Willow.

Twist Bioscience

Twist Bioscience specializes in synthetic DNA production, which is foundational for biosynthesis and directly competes with Willow's technology platform.

Co-Diagnostics uses molecular diagnostics for detection of DNA or RNA, which can be seen as a competing technology for applications targeted by Willow's biosynthesis.

Pacific Biosciences of California

Pacific Biosciences offers sequencing technologies that, while not directly competitive, are part of the broader biotech ecosystem that intersects with Willow's market.

About

Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.

Show more...

CEO

Mr. Travis Doupe

Employees

19

Country

CA

ISIN

CA97111B4047

Listings